|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,175.55 INR | -0.92% |
|
-2.65% | -7.51% |
Sales 2025 by Business Segment
Sales 2025 by Geography
Historical Breakdown of Revenue by Business Segments
Gross Profit: Breakdown by Business Segment
| Fiscal Period: March | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Pharmaceutical Products | ||||||||||
Global Generics | 147B | 173B | 206B | 245B | 290B | |||||
Gross Profit | 91.11B | 103B | 133B | 154B | 180B | |||||
D&A | 3.44B | 3.08B | 3.27B | 3.89B | 4.16B | |||||
Proprietary Products | 523M | 1.61B | - | - | - | |||||
Gross Profit | 482M | 1.59B | - | - | - | |||||
Medicinal Chemicals and Botanical Products | ||||||||||
Pharmaceutical Services and Active Ingredients (PSAI) | 38.89B | 37B | 36.65B | 29.8B | 43.24B | |||||
Gross Profit | 9.43B | 6.82B | 4.72B | 6.92B | 9.16B | |||||
D&A | 2.58B | 2.51B | 2.77B | 2.81B | 2.96B | |||||
Biological Products | ||||||||||
Others | 2.81B | 2.87B | 3.04B | 3.91B | 2.14B | |||||
Gross Profit | 2.06B | 2.16B | 1.91B | 2.42B | 1.66B | |||||
D&A | 48M | 42M | 69M | 37M | - | |||||
Inter-Segment Revenues | - | - | - | - | -9.39B |
Geographical Revenue Distribution History
| Fiscal Period: March | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
United States | 76.7B | 80.56B | 107B | 136B | 149B | |||||
Total Assets | 7.63B | 3.85B | 3.28B | 3.66B | 4.34B | |||||
CAPEX | -2.16B | -260M | -532M | -1.28B | - | |||||
Others | 60.95B | 68.96B | 67.47B | 72.82B | 94.4B | |||||
Total Assets | 5.11B | 5.24B | 5.34B | 7.17B | 11.81B | |||||
CAPEX | -1.03B | -1.2B | -732M | -2.75B | - | |||||
India | 36.25B | 43.99B | 50.5B | 48.47B | 55.83B | |||||
Total Assets | 75.28B | 83.17B | 91.87B | 100B | 121B | |||||
CAPEX | -27.88B | -15.58B | -18.36B | -19.57B | - | |||||
Russia | 15.82B | 20.88B | 21.23B | 22.3B | 25.96B | |||||
Total Assets | 11.66B | 4.75B | 5.07B | 10.89B | 73.62B | |||||
CAPEX | -3.76B | -195M | -1.21B | -7.72B | - | |||||
Total Assets | 1.09B | 1.26B | 776M | 648M | 657M |
Select your edition
All financial news and data tailored to specific country editions
